Vimarsana
Biggest News Aggregation in the World

Page 10 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Network Today - Breaking & Trending Today

Early treatment offers chance at medication-free remission for pediatric HIV patients - Vimarsana News

Early treatment offers chance at medication-free remission for pediatric HIV patients

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

Readers Slam Hospital Monopolies and Blame the Feds for Understaffed Nursing Homes - Vimarsana News

Readers Slam Hospital Monopolies and Blame the Feds for Understaffed Nursing Homes

California Healthline gives readers a chance to comment on a recent batch of stories.

Study affirms benefit of very early antiretro - Vimarsana News

Study affirms benefit of very early antiretro

<p>A study of more than 50 babies through 2 yeard old in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days &mdash; rather than within weeks or months &mdash; of life can safely suppress amounts of HIV in the blood to undetectable levels. Findings of the study, which was co-led by&nbsp;<a href="https://www.hopkinsmedicine.org/johns-hopkins-childrens-center">Johns Hopkins Children&rsquo;s Center</a>&nbsp;physician-scientist and resear...

On World AIDS Day, doctors and advocates pressure Georgia to expand Medicaid, equitable treatment &#x2013; WABE - Vimarsana News

On World AIDS Day, doctors and advocates pressure Georgia to expand Medicaid, equitable treatment &#x2013; WABE

Amplifying Atlanta

Source: wabe.org
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript - Vimarsana News

Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript

Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.